Analyst Ratings – Page 2 – Market Globalist

Analyst Ratings

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters [AEO] rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from $23,

Analyst Ratings

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike [NKE] rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note dated

Analyst Ratings

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Raymond James took its Atlantic Capital [ACBI] rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts also

Analyst Ratings

Tapestry [TPR] Stock Gets Reiterated At KeyBanc. It’s Still Overweight

KeyBanc maintained its Tapestry [TPR] rating to the equivalent of Overweight but changed the price target to $38.0 from $35, in a research note dated

Analyst Ratings

Silgan Hldgs [SLGN] Unchanged to Overweight at KeyBanc

KeyBanc maintained its Silgan Hldgs [SLGN] rating to the equivalent of Overweight but changed the price target to $40.0 from $39, in a research note

Analyst Ratings

Glu Mobile [GLUU] gets a downgrade to Neutral from Goldman Sachs

Goldman Sachs took its Glu Mobile [GLUU] rating to the equivalent of Neutral from Buy, and the price target to $10.4, in a research note

Analyst Ratings

Goldman Sachs downgrades IMAX to Neutral and price target to $17.9

Goldman Sachs took its Imax [IMAX] rating to the equivalent of Neutral from Buy, and the price target to $17.9 from $15, in a research

Analyst Ratings

Truist Securities cuts Magnite [MGNI]’s rating to Hold; PT at $37

Truist Securities took its Magnite [MGNI] rating to the equivalent of Hold from Buy, and the price target to $37.0 from $12, in a research

Analyst Ratings

HC Wainwright & Co. reiterates Xenetic Biosciences [XBIO] rating to Buy and sets new price target at $$2.50

HC Wainwright & Co. maintained its Xenetic Biosciences [XBIO] rating to the equivalent of Buy but changed the price target to $5.0 from $2, in

Analyst Ratings

Ternium [TX] Upgraded to Outperform at Credit Suisse

Credit Suisse took its Ternium [TX] rating to the equivalent of Outperform from Neutral, and the price target to $41.5, in a research note dated

Category: Analyst Ratings

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Tapestry [TPR] Stock Gets Reiterated At KeyBanc. It’s Still Overweight

Silgan Hldgs [SLGN] Unchanged to Overweight at KeyBanc

Glu Mobile [GLUU] gets a downgrade to Neutral from Goldman Sachs

Goldman Sachs downgrades IMAX to Neutral and price target to $17.9

Truist Securities cuts Magnite [MGNI]’s rating to Hold; PT at $37

HC Wainwright & Co. reiterates Xenetic Biosciences [XBIO] rating to Buy and sets new price target at $$2.50

Ternium [TX] Upgraded to Outperform at Credit Suisse

Quick Links

Categories